Strategy BICO 2.0
We aim to be the first-choice lab automation partner and provider of selected workflows to pharma and biotech.
BICO’s updated strategy was launched during the Capital Markets Day held on September 17, 2024, with focus on the Group’s strategic direction for sustainable profitable growth.
Strategic Priorities for the Group
01.
Drive Commercial Excellence
· Enable End-to-End Lab automation
· Further develop integrated data, AI, and SW solutions
· Ensure Regulatory Compliance Readiness
· Provide Scientific Workflow Solutions
· Increase recurring revenue
02.
Strategic Review
· Customer centric R&D
· Gate stage process for product development
· Continually assess the strategic fit across our portfolio of assets
03.
Invest in People & Culture
· Foster culture and strong leadership
· Plan, attract, and retain talent
· Harmonize, engage, and reward
· Deliver global HR operational excellence
04.
Operational Excellence
· Establish global sourcing organization
· Roll out of strategic CDMO partnership model
· Implementation of a global QA & RA organization
· Streamlining and cost reduction in logistics
· Continued focus on inventory reduction and facility footprint reduction
Strategic Commercial Focus Areas
Our Solution to the Customer Needs
Enable end-to-end Lab Automation
further develop integrated data, AI and SW Solutions
Ensure Regulatory Compliance Readiness
Provide Scientific workflow solutions
